about
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleedingUsefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary eventsResidual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapyImpact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosisOxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data.Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS gene polymorphisms in atrial fibrillation susceptibility.Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis.Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older personsInflammatory and antioxidant pattern unbalance in "clopidogrel-resistant" patients during acute coronary syndromeRetinal vein thrombosis: risk factors, pathogenesis and therapeutic approach.Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention.Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.Association between homocysteine, vitamin B(6) concentrations and inflammation.Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events--a meta-analysis.Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.A khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trialCytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis.Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.Antiplatelets in acute coronary syndrome: personal perspectives.Gender and anti-thrombotic therapy: from biology to clinical implications.Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper.Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.On-treatment platelet reactivity: State of the art and perspectives.Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus.A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy.Increased homocysteine and lipoprotein(a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes.High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI.Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis).High-throughput multiplex single-nucleotide polymorphism (SNP) analysis in genes involved in methionine metabolism.Impact of a cardiac rehabilitation program and inflammatory state on endothelial progenitor cells in acute coronary syndrome patients.Erratum to: 'Mediterranean versus vegetarian diet for cardiovascular disease prevention (the CARDIVEG study): study protocol for a randomized controlled trial'.Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase.High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion.
P50
Q26829251-7D6F4C67-911A-4F24-AC5E-E61E9AEC9C36Q28200883-9AAF47B5-2958-4730-B26E-E5A0D98093DCQ28212833-6BD25DF7-7A83-472F-8F85-645A4DDA5A3AQ28213327-5BA4F0D9-E004-4CE3-AE27-8709BFCC3BA8Q30362121-A906493D-B65B-40BF-AD38-FC1CF3B470B3Q31028203-BBEB7409-3C03-4E27-ABB3-4A638B158D41Q33286816-7441D3CD-AB82-46FD-8D7E-47EE0945671CQ33293250-713C57DD-DA43-4175-A150-7D8F297057F7Q33529765-E3B10060-7391-4894-9D48-6ED3D91B882EQ34060015-E699067D-CF3F-49C8-B63D-CA0B2C8C1D82Q34138655-B02ED1EC-3104-4E7D-81F2-CF3F67581AA8Q35250401-283C690E-4D72-4547-B782-9252DF68E36BQ35297991-54942368-4E89-4B65-A5F0-7F17FA1F78D0Q35610354-E1C7D1B0-E14C-426B-A24C-A20FC9AC056DQ35930428-49D378E6-7FB8-47F6-9C2E-3AEB776B5B68Q36996487-7E55CCEC-D548-4C8F-8A5D-F3B6087C203EQ37074802-68654613-EA2C-43A1-9D6C-0E6F27E3D1ADQ37693951-89DA0E5E-4815-41A4-BA40-6A34B432E2A1Q37694302-C3466E42-DAF8-4754-8B4F-D8AA1FB305E3Q37721156-65C12462-74A3-42EE-838A-66665F15F38DQ37786695-58CD3649-326D-42DA-A7E2-D59EF12F6C61Q38068595-10C3665B-D13E-473F-89B7-45370F3651BFQ38182428-1EB0D51D-C88F-4CA9-AF62-B5E5781D12DFQ38229559-BA014C10-E3A2-45AF-B9A6-BB4C572D0CB0Q38364982-5468492C-473C-4815-9E0A-ADCD0E3A016CQ38484239-38A6C809-3109-48BB-BF9A-3921BD8050E3Q38621049-0432939C-F5D8-4E30-A6C6-4BCD482EAA3CQ39996910-7A90D399-375A-4363-8A97-CD5C1D04CF7DQ40154187-E593EDC4-9ED2-42BD-9038-61EE0908C4AEQ40580246-6740B7F0-C41B-4D9F-BE53-17FEF8286B4BQ40719450-EBD6B7FC-3F0C-42B9-A375-B3EB22421FD6Q40771534-7B36574A-D832-4684-B914-3F40D3DA1D5AQ40979067-A5701A6D-DE9D-48B2-8056-DBA978F1587AQ41343293-26F31441-C349-4625-BD0E-BB71CA005EADQ42167125-748AF3D3-E637-472F-9820-D2E82CE05466Q42506943-4307DEB0-79B6-406C-8B98-F43FE35642F6Q42777740-765C6199-3306-4D4F-B4DD-466146A6A111Q43037462-E77A983C-752B-44A9-8457-B15BF7AB79FEQ43217793-5580B294-FC43-4089-B7AE-9F77F27D8861Q43223855-AD3745ED-4342-4720-B99E-C8513A0E1A1C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rossella Marcucci
@ast
Rossella Marcucci
@en
Rossella Marcucci
@es
Rossella Marcucci
@nl
Rossella Marcucci
@sl
type
label
Rossella Marcucci
@ast
Rossella Marcucci
@en
Rossella Marcucci
@es
Rossella Marcucci
@nl
Rossella Marcucci
@sl
prefLabel
Rossella Marcucci
@ast
Rossella Marcucci
@en
Rossella Marcucci
@es
Rossella Marcucci
@nl
Rossella Marcucci
@sl
P106
P1153
56246030600
P21
P31
P496
0000-0001-9549-7176